Purchase Order HHSN261201800265P

<p>The National Cancer Institute awarded a purchase order to Gryphon Scientific, LLC for $63,300 on September 23, 2019, to identify radiation-injury markers predicting organ damage and survival following whole-body irradiation in mouse and minipig models. Work is performed in Beverly, Massachusetts under a firm fixed-price structure, with completion targeted for November 22, 2019. The order originated from a Special Notice posted August 19, 2019 with a due date of August 26, 2019.</p>

<p>The National Cancer Institute awarded a purchase order to Gryphon Scientific, LLC for $9,895.00 with a firm fixed price on July 26, 2017, with ultimate completion by August 28, 2017. No set-aside category was used. Place of performance is Beverly, Massachusetts. The source does not specify the procured items or services.</p>

<p>The National Cancer Institute awarded a purchase order to Gryphon Scientific, LLC for $13,340.00 on December 1, 2017, with an ultimate completion date of November 30, 2018. No set-aside was used. Performance will take place in Bethesda, Maryland. The order is priced as fixed price with economic price adjustment. Specific requirements are not detailed in the source.</p>

<p>The National Cancer Institute awarded a purchase order to Genus Biosystems Inc. for $57,564.00 on September 17, 2018. The order, which carried no set-aside designation, covers exploration of gene expression and microRNA expression changes in tumors exposed to radiation, with and without specified treatment modalities. Work is performed in Northbrook, Illinois. The order is firm fixed price and carries an ultimate completion date of September 16, 2019.</p>

<p>The National Cancer Institute issued a purchase order to Gryphon Scientific, LLC for $24,100 on April 3, 2019, to identify biomarker signatures in the minipig model for different radiation doses and time points and annotate unannotated minipig probes. Work is performed in Bethesda, Maryland. The contract carries fixed-price pricing with economic price adjustment and has an ultimate completion date of April 2, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $11,440 on March 8, 2018, with completion by March 27, 2019. Work is performed in Bethesda, Maryland. The order is firm fixed price with no set-aside applied. Specific scope of supply is not detailed in the award record.</p>

<p>The National Cancer Institute awarded a purchase order to Genus Biosystems Inc. valued at $55,879.20 on March 15, 2019, for identifying radiation-induced RNA markers in lung and liver tissue samples from whole-body irradiation studies. Work is performed in Northbrook, Illinois. The order carries a firm fixed price and was completed by August 15, 2019. The procurement originated from a special notice posted February 14, 2019, with a response deadline of February 28, 2019.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC on June 7, 2018, with a ceiling value of $4,300.08 and ultimate completion date of June 14, 2019. The order is priced as firm fixed price with no set-aside. Place of performance is Marlborough, Massachusetts. The specific procurement details and commodity description are not provided in the source material.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $24,441.58 on April 24, 2018, to supply laboratory supplies. The order carries no small business set-aside. Performance occurs in Marlborough, Massachusetts. Ultimate completion is May 23, 2018. The contract uses firm fixed price terms.</p>

<p>The National Cancer Institute awarded a purchase order to Biocytogen LLC for $10,000.00 on April 3, 2018. Work is performed in Worcester, Massachusetts. The order carries a firm fixed price for commercial items, with ultimate completion on May 3, 2018. No small business set-aside was applied.</p>